We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WULF:NASDAQTeraWulf Inc. Analysis

Data as of 2026-09-16 - not real-time

$14.49

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind TeraWulf Inc. is bearish at $14.49, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 23.0%. RSI sits at 40.2, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $14.24 and resistance around $18.08.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 144.9% above the current price. Revenue is contracting at 6.0%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 81.2%, a beta of 3.36 and a maximum drawdown of 50.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.

Top Market Events

102 MW of revenue-generating critical IT capacity online at Lake Mariner, with an additional 336 MW under construction...TeraWulf Inc. stocks have been trading down by -5.77 percent amid bearish sentiment over rising operational and...TeraWulf Inc. stocks have been trading down by -5.77 percent amid heightened concerns over regulatory risks facing its...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 17.99
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 17.99
  • Analyst targets imply +144.9% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Analyst targets imply +144.9% versus the current price
  • Negative return on equity of -1211.8%
  • Revenue contracting at -6.0%

Key Metrics & Analysis

Financial Health

Revenue Growth-6.00%
P/E Ratio-60.4
ROE-1211.81%
ROA-4.79%
Debt/Equity3549.65
P/B Ratio49.1
Op. Cash Flow$-279156992
Free Cash Flow$-234116752
Industry P/E16.1

Technical Analysis

TrendBearish
RSI40.2
Support$14.24
Resistance$18.08
MA 20$15.90
MA 50$17.53
MA 200$17.99
MACDBullish
VolumeDecreasing
Fear & Greed Index90.71

Valuation

Target Price$35.48
Upside/Downside144.86%
GradeFair
TypeBlend

Risk Assessment

Beta3.36
Volatility81.24%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.